F&G Annuities & Life, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, dated March 24, 2025, details the completion of a public offering of common stock by F&G Annuities & Life, Inc. (F&G), a Delaware corporation and subsidiary of Fidelity National Financial, Inc. (FNF).
Key Financial Metrics and Transaction Details
- Offering Size: 8,000,000 shares of Common Stock ($0.001 par value).
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional 1,200,000 shares.
- Majority Shareholder Participation: Underwriters agreed to resell 4,500,000 shares to FNF at the same price paid by the underwriters.
- Use of Proceeds: Net proceeds are designated for general corporate purposes, including supporting organic growth opportunities.
- Financial Metrics: The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Agreements
The primary material change is the entry into an Underwriting Agreement dated March 20, 2025, with BofA Securities, Inc. and J.P. Morgan Securities LLC as representatives. The offering was registered under Form S-3ASR (File No. 333-282432). Additionally, F&G, FNF, and all directors and executive officers have agreed to a 90-day lock-up period, restricting the sale or transfer of F&G securities with limited exceptions.
Guidance, Outlook, and Risks
Management intends to utilize the capital raised to support organic growth. The filing includes standard forward-looking statements regarding the anticipated timing and closing of the offering. Risks and uncertainties that could cause actual results to differ from expectations are referenced in F&G's Annual Report on Form 10-K for the year ended December 31, 2024. No specific new risks or contingencies were detailed in this text beyond the standard disclaimer.
Investor Verification Checklist
- Verify the final offering price per share and total net proceeds, which are not explicitly stated in this summary text.
- Confirm whether the 1,200,000 share over-allotment option was exercised by the underwriters.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific indemnification terms and covenants.
- Check the Form 10-K for the year ended December 31, 2024, for detailed risk factors and historical financial performance.